879 results on '"Kouyos Roger D."'
Search Results
2. Transcriptional profile of Mycobacterium tuberculosis infection in people living with HIV
3. Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines
4. Molecular epidemiology of invasive Group A streptococcal infections before and after the COVID-19 pandemic in Switzerland
5. Assessing immunogenicity barriers of the HIV-1 envelope trimer
6. HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis
7. Antibiotic prophylaxis before dental procedures to prevent infective endocarditis: a systematic review
8. Identifying Contact Risks for SARS-CoV-2 Transmission to Healthcare Workers during Outbreak on COVID-19 Ward
9. Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years
10. Modifiable and nonmodifiable risk factors for non-ventilator-associated hospital-acquired pneumonia identified in a retrospective cohort study
11. Quantification of transgene expression in GSH AAVS1 with a novel CRISPR/Cas9-based approach reveals high transcriptional variation
12. Acquired HIV drug resistance mutations on first-line antiretroviral therapy in Southern Africa: Systematic review and Bayesian evidence synthesis
13. Impact of hormonal therapy on HIV‐1 immune markers in cis women and gender minorities.
14. Assessing the Role of Bacterial Innate and Adaptive Immunity as Barriers to Conjugative Plasmids.
15. Recommendations on data sharing in HIV drug resistance research
16. The impact of public health interventions on the future prevalence of ESBL-producing Klebsiella pneumoniae: a population based mathematical modelling study
17. Assessing the role of bacterial innate and adaptive immunity as barriers to conjugative plasmids
18. Genetic diversity from proviral DNA as a proxy for time since HIV-1 infection
19. Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
20. Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?
21. Cohort Profile: The Zurich Primary HIV Infection Study
22. Deciphering factors linked with reduced SARS-CoV-2 susceptibility in the Swiss HIV Cohort Study
23. Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort
24. Genetic Diversity From Proviral DNA as a Proxy for Time Since HIV-1 Infection.
25. Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk.
26. Using viral diversity to identify HIV-1 variants under HLA-dependent selection in a systematic viral genome-wide screen.
27. Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics
28. Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+decline
29. Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
30. Cohort Profile: The Zurich Primary HIV Infection Study
31. The effect of combining antibiotics on resistance: A systematic review and meta-analysis
32. Author Response: The effect of combining antibiotics on resistance: A systematic review and meta-analysis
33. Quantifying the impact of treatment history on plasmid-mediated resistance evolution in human gut microbiota
34. Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization
35. Correction to: Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study
36. Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study
37. Author Correction: Efficient microbial colony growth dynamics quantification with ColTapp, an automated image analysis application
38. Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity
39. Impact of an electronic alert on prescription patterns of meropenem, voriconazole and caspofungin
40. The path of least resistance: aggressive or moderate treatment?
41. Characterization and Determinants of Long-Term Immune Recovery Under Suppressive Antiretroviral Therapy.
42. Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study.
43. No Effect of Pegylated Interferon-α on Total HIV-1 DNA Load in HIV-1/HCV Coinfected Patients
44. High Rates of Subsequent Asymptomatic Sexually Transmitted Infections and Risky Sexual Behavior in Patients Initially Presenting With Primary Human Immunodeficiency Virus-1 Infection
45. Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
46. Quantification of within-patient Staphylococcus aureus phenotypic heterogeneity as a proxy for the presence of persisters across clinical presentations
47. Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking—A modelling study
48. Development of a high-throughput bead based assay system to measure HIV-1 specific immune signatures in clinical samples
49. Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment
50. Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.